NextPlat (NXPL) Enterprise Value (2010 - 2026)
NextPlat's (NXPL) quarterly Enterprise Value came in at $6.5 million in Q2 2026, up 140.53% year-over-year from $2.7 million in Q2 2025, and up 812.79% quarter-over-quarter from -$908298.5 in Q1 2026.
Analysis
NextPlat (NXPL) Enterprise Value (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Enterprise Value for 17 consecutive years, with $6.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Enterprise Value rose 140.53% year-over-year to $6.5 million in Q2 2026; TTM through Jun 2026 was $6.5 million, a 140.53% increase from a year earlier, with the FY2025 full-year figure at $591976.9, down 75.51% from the prior year.
- Enterprise Value was $6.5 million for Q2 2026 at NextPlat, up from -$908298.5 in the prior quarter.
- Over five years, Enterprise Value peaked at $30.3 million in Q2 2023 and troughed at -$6.8 million in Q4 2022.
- A 5-year average of $8.3 million and a median of $6.3 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 1294.98% in 2023 and tumbled 123.13% in 2026, its largest moves.
- Over 5 years, Enterprise Value stood at -$6.8 million in 2022, then jumped by 403.23% to $20.5 million in 2023, then plunged by 88.2% to $2.4 million in 2024, then sank by 75.51% to $591976.9 in 2025, then surged by 993.67% to $6.5 million in 2026.
- The last three Enterprise Value figures came in at $6.5 million (Q2 2026), -$908298.5 (Q1 2026), and $591976.9 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.47 Mn |
| Mar 31, 2026 | -908,298.47 |
| Dec 31, 2025 | 591,976.91 |
| Sep 30, 2025 | 7.95 Mn |
| Jun 30, 2025 | 2.69 Mn |
| Mar 31, 2025 | 3.93 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Sep 30, 2024 | 13.75 Mn |
| Jun 30, 2024 | 6.05 Mn |
| Mar 31, 2024 | 20.99 Mn |
| Dec 31, 2023 | 20.49 Mn |
| Sep 30, 2023 | 23.89 Mn |
| Jun 30, 2023 | 30.26 Mn |
| Mar 31, 2023 | 4.65 Mn |
| Dec 31, 2022 | -6.76 Mn |
| Sep 30, 2022 | 8.75 Mn |
| Jun 30, 2022 | -2.53 Mn |
| Mar 31, 2022 | 6.53 Mn |
| Dec 31, 2021 | -4.05 Mn |
| Sep 30, 2021 | 15.85 Mn |